Funding News

India's Fertility Crisis Is Driving M&A: Indira IVF Acquires Kolkata's Abha Surgy Centre — West Bengal's Fertility Rate Is 1.3, Far Below Replacement Level

By Mustafa Shariff, Editor in Chief · April 16,2026 · 5 min read

Summary

• indira IVF Acquires Abha Surgy Centre Kolkata: Inside India's Fertility Care Consolidation and the Demographics Driving It
• Indira IVF has acquired a stake in Kolkata's 30-year-old Abha Surgy Centre. Here is the full story of India's fertility care sector consolidation and the demographic shifts making it one of healthcare's fastest-growing segments.

India's fertility care sector is quietly experiencing one of the most sustained M&A waves in Indian healthcare — and the demographic data underlying it explains exactly why. Indira IVF Hospital Limited, India's largest IVF network with presence across hundreds of cities, has acquired a stake in Abha Surgy Healthcare Private Limited, the operator of Kolkata's Abha Surgy Centre — a fertility institution that has been serving patients across eastern India and neighbouring countries including Bangladesh, Nepal, Bhutan, and Sri Lanka for over three decades.

The acquisition brings together Abha Surgy Centre's 30 years of clinical heritage — more than 10,000 babies delivered, a team that has grown from 5 members to 120+ specialists, led by renowned infertility experts Dr Bani Kumar Mitra and Dr Konkon Das Mitra — with Indira IVF's network scale, technological capabilities, and national platform. The strategic rationale is direct: the partnership expands fertility care access across eastern India at a moment when the demographic indicators are creating unmistakable demand.

The Demographics Behind the Deal

The fertility care sector's growth in India is not primarily a lifestyle story — it is a demographic reality. The data from West Bengal illustrates this with particular clarity. According to the Sample Registration System Statistical Report 2023, West Bengal's total fertility rate has declined from 1.7 in 2013 to 1.3 in 2023 — significantly below the replacement level of 2.1. The state now records the lowest urban total fertility rate in India and the second-lowest rural rate nationally.

West Bengal's fertility trajectory is an accelerated version of a pattern playing out across India's urban states. Late marriage, career prioritisation, lifestyle changes, rising rates of polycystic ovarian syndrome and other fertility-affecting conditions, and increased awareness of fertility treatment are all contributing to a growing gap between reproductive intention and natural fertility. India's overall fertility rate has declined below replacement level in most urban centres, creating structural long-term demand for assisted reproductive technology.

Nationally, India's IVF market has been growing at 15-20% annually, driven by rising infertility rates, decreasing social stigma around fertility treatment, improving insurance coverage for ART procedures, and the expansion of affordable IVF providers into tier-2 and tier-3 cities. The total number of IVF cycles performed in India annually is estimated to have exceeded 500,000 — making India one of the two or three largest IVF markets in the world.

What Abha Surgy Centre Brings

Abha Surgy Centre is not simply a Kolkata clinic — it is a regional institution with a three-decade track record and deep patient trust across eastern India and its neighbouring countries. Dr Bani Kumar Mitra, who co-founded the centre and has shaped its patient-first philosophy, has built one of the most recognised fertility brands in eastern India. Dr Konkon Das Mitra, described as one of India's earliest clinical embryologists with advanced training from Singapore under Arif Bongso, brings world-class scientific credentials to the centre's laboratory operations.

The acquisition gives Indira IVF a specifically valuable asset: an established, trusted clinical brand in Kolkata and eastern India that has taken decades to build and cannot be replicated by simply opening a new clinic. Trust in fertility treatment is deeply personal — patients choose their IVF provider based on recommendations from other patients, doctor credibility, and institutional track record. Abha Surgy's three decades of delivery create a patient relationship network that would take years to rebuild organically.

The Broader IVF Consolidation Story

The Indira IVF-Abha Surgy deal is part of a pattern of consolidation in India's fertility care sector. Indira IVF itself has been the most aggressive acquirer in the IVF space, consistently buying established regional fertility clinics and bringing them into its national platform. Competitors including Nova IVF, Oasis Fertility, Milann, and Cloudnine have been pursuing similar acquisition strategies, recognising that the Indian fertility care market rewards network scale, brand credibility, and clinical standardisation.

BHC Perspective

At Bengaluru Health Community, the Indira IVF-Abha Surgy deal represents an important signal for healthcare founders and investors building in the women's health and reproductive care space. Fertility care is one of the highest-growth, highest-margin segments in Indian healthcare — and it is still significantly fragmented. The acquisition wave underway is creating both consolidation pressure on standalone clinics and commercial opportunity for health-tech companies building in IVF cycle management, embryology AI, patient engagement platforms, and telemedicine-first fertility consultation models.

Frequently Asked Questions

Q: What did Indira IVF acquire?
A: Indira IVF Hospital Limited acquired a stake in Abha Surgy Healthcare Private Limited, which operates Abha Surgy Centre in Kolkata — a 30-year-old fertility institution with 10,000+ babies delivered, led by Dr Bani Kumar Mitra and Dr Konkon Das Mitra.

Q: Why is West Bengal's fertility rate significant for this deal?
A: West Bengal's total fertility rate has declined to 1.3 in 2023 — well below the replacement level of 2.1 and among India's lowest. This creates structural demand for assisted reproductive technology across eastern India.

Q: How large is India's IVF market?
A: India's IVF market is estimated to exceed 500,000 cycles annually, growing at 15-20% per year, driven by rising infertility rates, declining social stigma, improving insurance coverage, and expansion into smaller cities.